[China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call HANGZHOU, China--(PR NEWSWIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that the Company will hold its second quarter fiscal 2014 earnings call on Friday November 15, 2013 at 8:00 a.m. Eastern Time. The Company plans to]
[China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call HANGZHOU, China--(PR NEWSWIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that the Company will hold its second quarter fiscal 2014 earnings call on Friday November 15, 2013 at 8:00 a.m. Eastern Time. The Company plans to]
[NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on November 6, 2013, it received notification from NASDAQ granting the Company an additional 180-day period, or until May 5, 2014,]
[NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on November 6, 2013, it received notification from NASDAQ granting the Company an additional 180-day period, or until May 5, 2014,]
[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014 First Quarter Earnings Results and Schedules Conference Call for August 19, 2013 Fiscal Year 2014 First Quarter Highlights: ● Revenues from retail sales increased to $10.9 million, up 21.9% from the prior period ● Gross profit from retail sales were $2.8 million, down 19.8% from the prior period ● Revenue from wholesale]
[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014 First Quarter Earnings Results and Schedules Conference Call for August 19, 2013 Fiscal Year 2014 First Quarter Highlights: ● Revenues from retail sales increased to $10.9 million, up 21.9% from the prior period ● Gross profit from retail sales were $2.8 million, down 19.8% from the prior period ● Revenue from wholesale]
[FORM 10-Q þ For the quarterly period ended June 30, 2013 or o For the transition period from _______________ to ___________________ 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Lei Liu Chief Executive Officer EX-32.1 4 f10q0613ex32i_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF EXECUTIVE OFFICER *] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0613ex32ii_chinajojo.htm SECTION 906 CERTIFICATION BY THE CORPORATION?S CHIEF FINANCIAL OFFICER *]
[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2013 Earnings Results and Schedules Conference Call for July 5, 2013 Fiscal Year 2013 Highlights: · Revenues from retail sales decreased to $40.7 million, down 38.4% from the prior period · Gross profit was $14.6 million, down 46.9% from the prior year · Net loss was $14.3 million · Diluted and basic loss]
[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2013 Earnings Results and Schedules Conference Call for July 5, 2013 Fiscal Year 2013 Highlights: · Revenues from retail sales decreased to $40.7 million, down 38.4% from the prior period · Gross profit was $14.6 million, down 46.9% from the prior year · Net loss was $14.3 million · Diluted and basic loss]
[FORM 10-K þ For the fiscal year ended March 31, 2013 or o For the transition period from _______________________ to ___________________ 001-34711 CHINA JO-JO DRUGSTORES, INC . (Exact name of issuer as specified in its charter) Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District,] [List of Subsidiaries 1. Renovation Investment (Hong Kong) Co., Ltd. (“Renovation”) is a Hong Kong company and is wholly-owned by the Company. 2. Hangzhou Jiutong Medical Technology Co., Ltd. is a Chinese company and is wholly-owned by Renovation. 3. Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. (“Shouantang Technology”) is a Chinese company and is wholly-owned by Renovation. 4. Zhejiang Jiuxin Investment] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-171849) of China Jo-Jo Drugstores, Inc. and subsidiaries of our report dated July 1, 2013 relating to the consolidated financial statements, which appear in this Form 10-K. New York, New York July 1, 2013 EX-23 3] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Lei Liu Chief Executive Officer July 1, 2013 EX-32.1 6 f10k2013ex32i_chinajojo.htm SECTION 906 CERTIFICATION BY] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Ming Zhao Ming Zhao Chief Financial Officer July 1, 2013 EX-32.2 7 f10k2013ex32ii_chinajojo.htm SECTION 906 CERTIFICATION BY]
